Institution statistics

IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE - Italy 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:900-1000
Total Project Funding per Partner:700-800
Total Number of Projects:800-900
Networking Rank (Reputation):> 1000
Partner Constancy:700-800
Project Leadership Index:700-800
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:68
Networking Rank (Reputation):> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:46
Project Leadership Index:75
Diversity Index:23
2011
Criterium:Position:
Overall Score:800-900
Total Project Funding:> 1000
Total Project Funding per Partner:200-300
Total Number of Projects:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:500-600
2010
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding:500-600
Total Project Funding per Partner:100-200
Total Number of Projects:500-600
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:500-600
Total Project Funding:300-400
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Networking Rank (Reputation):600-700
Partner Constancy:400-500
Project Leadership Index:400-500
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 48
As coordinator: 1
As participant: 38
Sole participant: 9
Coordinator / Participant Ratio: 0.03*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 4.011.939 261.500 1
2018 168.277 3.605.245 426.339 1 1
2017 2.619.527 149.950 2.769.477 2 1
2016 348.554 5.981.519 2.597.866 2 2
2015 149.425 10.966.184 718.736 1 2
2014 0 1.999.800 1.999.800 1
2013 0 15.066.041 3.279.881 4
2012 188.612 7.452.001 809.879 1 2
2011 179.584 4.622.400 4.801.984 1 2
2010 0 11.997.580 463.700 1
2009 0 20.110.555 5.396.182 5
2008 2.390.983 27.575.703 1.902.423 1 4
2007 0 2.580.000 198.462 1
2006 143.746 14.823.800 1.018.460 1 2
2005 0 12.595.540 1.879.588 2
2004 0 52.911.349 2.360.994 7
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
KAROLINSKA INSTITUTE9
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE8
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE7
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR6
UNIVERSITAET ZU KOELN5
DEUTSCHES KREBSFORSCHUNGSZENTRUM4
ISTITUTO EUROPEO DI ONCOLOGIA4
KING'S COLLEGE LONDON4
RUPRECHT KARLS UNIVERSITAET HEIDELBERG4
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE4
UNIVERSITAIR MEDISCH CENTRUM UTRECHT4
UNIVERSITE DE GENEVE4
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE3
DANDO WEISS & COLUCCI LIMITED3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS3
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT3
MEDIZINISCHE UNIVERSITAET WIEN3
TECHNION ISRAEL INSTITUTE OF TECHNOLOGY3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD3
THE UNIVERSITY OF EDINBURGH3
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF3
UNIVERSITY COLLEGE LONDON3
UNIVERSITY OF COPENHAGEN3
UNIVERSITY OF HELSINKI3
ATLAS BIOLABS2
CANCER RESEARCH UK2
COUNCIL FOR THE CENTRAL LABORATORY OF THE RESEARCH COUNCILS2
DRUG DISCOVERY FACTORY BV2
FONDAZIONE PIEMONTESE PER LA RICERCA SUL CANCRO ONLUS2
FONDAZIONE TELETHON2
FREIE UNIVERSITAET BERLIN2
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III2
INSERM TRANSFERT2
INSTITUT PASTEUR2
IRCCS ASSOCIAZIONE LA NOSTRA FAMIGLIA 'ISTITUTO SCIENTIFICO EUGENIO MEDEA'2
ITAE SUOMEN YLIOPISTO2
JOHANNES GUTENBERGUNIVERSITAET MAINZ2
KAROLINSKA INSTITUTET2
KOBENHAVNS UNIVERSITET2
LUDWIG INSTITUT FUER KREBSFORSCHUNG2
LUDWIG INSTITUT FUER KREBSFORSCHUNG2
MEDICAL RESEARCH COUNCIL2
MILTENYI BIOTEC2
MOSAIQUES DIAGNOSTICS2
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS2
NATIONAL HELLENIC RESEARCH FOUNDATION2
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS2
THE HEBREW UNIVERSITY OF JERUSALEM2
THE NETHERLANDS CANCER INSTITUTE/ANTONI VAN LEEUWENHOEK HOSPITAL2
UNIVERSITAET BERN2
UNIVERSITAET STUTTGART2
UNIVERSITE D'ARTOIS2
UNIVERSITY OF AARHUS2
UNIVERSITY OF DUNDEE2
UNIVERSITY OF GENEVA2
UNIVERSITY OF KUOPIO2
UNIVERSITY OF NEWCASTLE UPON TYNE2
UNIVERSITY OF TURKU2
UPPSALA UNIVERSITET2
AARHUS UNIVERSITETSHOSPITAL SKEJBY1
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACCELERON MEDICINES1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
AGENDIA BV1
ALMA MATER STUDIORUM UNIVERSITY OF BOLOGNA CIG CENTRO INTERDIPARTIMENTALE "L GALVANI"1
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA1
AMC MEDICAL RESEARCH BV1
ANAXOMICS BIOTECH S L1
ANGIOGENETICS SWEDEN AB1
ARK THERAPEUTICS GROUP LIMITED1
AZIENDA OSPEDALE SAN MARTINO E CLINICHE UNIVERSITARIE CONVENZIONATE1
BAXTER INNOVATIONS1
BAYER INNOVATION1
BEJING GENOMICS INSTITUTE1
BEREICH HUMANMEDIZIN DER GEORG AUGUST UNIVERSITAET GOETTINGEN1
BEREICH HUMANMEDIZIN DER GEORGAUGUSTUNIVERSITAET GOETTINGEN1
BIOCONTRACT SP ZOO1
BIOHYOS AB1
BIOLUTION1
BIOMEDCODE ELLAS ANONIMI ETERIA EPISTIMONIKIS KAI TEXNOLOGIKIS EREVNASKAI EMBORIKIS EKMETALLEFSIS EPHARMOGON IATRIKIS1
BIOMEDCODE HELLAS1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
BIORIGEN1
BIOTECTURE1
BOEHRINGER INGELHEIM PHARMA GMBH & CO KG1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET EN MEDECINE1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET EN MEDICINE1
CENTRE EUROPEEN DE RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRE EUROPEEN POUR LA RECHERCHE EN BIOLOGIE ET MEDECINE1
CENTRE FOR PROCESS INNOVATION LIMITED1
CENTRE REGIONAL DE LUTTE CONTRE LE CANCER DE MONTPELLIER1
CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS1
CHANCELLORS MASTER AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL1
CHRISTIAN DE DUVE INSTITUTE OF CELLULAR PATHOLOGY1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
CONGENIA1
Constancy:

Total number of partners:437

Partner loyalty:
Frequent Partner: (> 2 projects): 102
Rare Partner: 335

Frequent / Rare Partner Ratio: 0.3

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES25
RTD HORIZONTAL TOPICS13
SOCIAL AND ECONOMIC CONCERNS9
INDUSTRY AND TECHNOLOGY3

Project overview:

Start dateProjectacronymrolefundingpartners
2019-03-01Joint Training and Research Program on Chromatin Dynamics and the DNA Damage Response aDDRessparticipant4.011.93919
2018-06-01Dynamic and Mechanical Role of Spectrin in Membrane-CytoskeletonInterplay MechanoSpectrincoordinator168.2771
2018-01-01COmbatting disorders of adaptive immunity with Systems MedICine COSMICparticipant3.605.24518
2017-09-01Inherited disfunctions of brain microcirculation V-EPCcoordinator2.451.2501
2017-07-01Regulation and reprogramming of alternative splicing in cellular transformation SPLICANCERcoordinator168.2771
2017-03-01The role of non coding RNA in organismal ageing RNAgingparticipant149.9501
2016-09-01Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network SYNTRAINparticipant3.990.26913
2016-07-01Mechanisms and regulators coordinating replication integrity and DNA damage tolerance. REPSUMODDTparticipant1.991.2501
2016-04-01ATR-mediated mechanotransduction and connections with the actin cytoskeleton MECHANOCHECKcoordinator180.2771
2016-04-01Crosstalk between nuclear envelope and DNA Damage Response: Role of nucleoporin TPR in the maintenance of genomic integrity ENVERESPcoordinator168.2771
2015-09-01Brain barriers training BtRAINparticipant3.067.40211
2015-06-01DDRNA-based cancer therapy targeted telomeres DDRNAcoordinator149.4251
2015-02-01The Development of Medium- and Large-Scale Sustainable Manufacturing Process Platforms for Clinically Compliant Solid Core Nanopharmaceuticals NANOFACTURINGparticipant7.898.7829
2014-06-01The role of essential DNA metabolism genes in vertebrate chromosome replication DNAMEREPparticipant1.999.8001
2013-07-017kDa TSLP as a novel type of anti-inflammatory agent to re-establish immune homeostasis 7TREIMHOparticipant146.9172
2013-06-01A novel direct role of non coding RNA in DNA damage response activation DDRNAparticipant2.329.2001
2013-03-01Novel nanotechnology-enabled system for endovascular in vivo near-infrared fluorescence molecular imaging and endovascular near-infrared targeted photodynamic therapy of atherosclerotic heart disease COSMOPHOS-NANOparticipant8.503.35219
2013-01-01Vascular Endothelial interactionS and SpEciaLization VESSELparticipant4.086.5729
2012-10-01The role of Chronic DNA damage in Ageing and Age-related pathology CodeAgeparticipant3.647.7079
2012-10-01Joint training and research network on Chromatin Dynamics and the DNA Damage Response ADDRESSparticipant3.804.29410
2012-03-01Mechanisms coordinating chromosome replication with transcription REPTRAcoordinator188.6121
2011-08-01THE ENDOCYTIC AND CYTOSKELETAL MATRIX IN THE PLASTICITY OF TUMOR CELL INVASION AND MIGRATION The MetaEndoMatrixparticipant2.232.2001
2011-08-01Transcriptional regulation of endothelial blood brain barrier differentiation by Wnt signaling Wnt for brainparticipant2.390.2001
2011-03-01Targeting of DNA deaminase AID via transcription and the RNA pol II elongation complex AID Recruitmentcoordinator179.5841
2010-01-01Activation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissue Endostemparticipant11.997.58022
2009-11-01Blood-brain barrier junctions as targets for paracellular drug delivery to the brain JUSTBRAINparticipant2.989.8457
2009-10-01Regulatory mechanisms coordinating replication integrity and intra-S repair REPSUBREPparticipant1.841.6001
2009-03-16A coordinated and structured international post-doctoral program to foster trans-national mobility and independent career of scientists in biomedicine SIPODparticipant1.011.9364
2009-03-01Molecular mechanisms of the regulation of mammary stem cell homeostasis and their subversion in cancer MAMMASTEMparticipant2.274.8621
2009-01-01Optimization of stem cell therapy for clinical trials of degenerative skin and muscle diseases OPTISTEMparticipant11.992.31220
2008-12-01Angiogenesis-inducing bioactive and bioresponsive scaffolds in tissue enginering ANGIOSCAFFparticipant11.631.24033
2008-03-01European stroke research network EUSTROKEparticipant9.953.91517
2008-01-01Genomic instability in cancer and precancer GENICAparticipant2.994.97911
2008-01-01Genomic instability and genomic alterations in pre-cancerous lesions and/or cancer GENINCAparticipant2.995.56914
2008-01-01Novel PREP1-dependent transcriptional networks in the control of insulin sensitivity PREPOBEDIAcoordinator2.390.9835
2007-01-01Signal transduction by Ubiquitination, a matter of location UBIREGULATORSparticipant2.580.00013
2006-10-01Cancer stem cells and asymmetric cell division ONCASYMparticipant2.823.8008
2006-07-01Mechanisms promoting the formation and migration of cruciform sister chromatid junctions during chromosome replication REPLI-HEMcoordinator143.7461
2006-01-01Role of Ubiquitin and Ubiquitin-like Modifiers in Cellular Regulation RUBICONparticipant12.000.00023
2005-05-01Mass spectrometry-based molecular diagnosis of breast cancer MS-MODIBparticipant1.795.5402
2005-01-01EURExpress, a European consortium to generate a web-based gene expression atlas by RNA in situ hybridization EUREXPRESSparticipant10.800.00011
2004-06-01Translational and Functional Onco-Genomics: from cancer-oriented genomic screenings to new diagnostic tools and improved cancer treatment. TRANSFOGparticipant6.000.00022
2004-05-01LYMPHANGIOGENOMICS: Genome-Wide Discovery and Functional Analysis of Novel Genes in Lymphangiogenesis LYMPHANGIOGENOMICSparticipant9.000.00016
2004-05-01Signalling and Membrane Trafficking in Transformation and Differentiation SIGNALLING & TRAFFICparticipant1.650.2009
2004-05-01GEnetics for Healthy Aging GEHAparticipant7.082.30024
2004-01-01Biocrystallography (X) on a highly integrated technology platform for European structural genomics BIOXHITparticipant9.993.84920
2004-01-01European Vascular Genomics Network EVGNparticipant9.000.00034
2004-01-01Extracellular Proteases and the Cances Degradome: Innovative Diagnostic Markers, Therapeutic Targets and Tumour Imaging Agents CANCERDEGRADOMEparticipant10.185.00036

Alias institution names:
  • IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum